Cleo Diagnostics Ltd, a medical diagnostics and devices company, focuses on the development of non-invasive blood based IVD tests to detect the presence and recurrence of ovarian cancer in Australia. It focuses on the development of triage, recurrence, and screening tests for ovarian cancer detection. The company was incorporated in 2021 and is based in Melbourne, Australia.
Stock data | 2023 | Change |
---|---|---|
Price | $0.28960519403548 | N/A |
Market Cap | $37.21M | N/A |
Shares Outstanding | 128.50M | N/A |
Employees | 0 | N/A |
Earnings | 2023 | Change |
---|---|---|
Earnings | -$1.16M | N/A |